Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 5229

The United States’ reliance on China for rare earth elements could soon come to an end, thanks to a new process that pulls the valuable metals from the ash left over when we burn coal.

Why it matters: The 17 rare earth elements aren’t actually rare — they’re all more common than gold, and one is more abundant than copper. But getting our hands on them is difficult because they’re widely dispersed in Earth’s crust and hard to extract through mining.

That’s a problem because we need rare earth elements to make a lot of products, from smartphones and satellites to electric cars and wind turbines.

Read more | >

According to the team, the new semiconducting cellulose nanopaper (CNP) can be tailored for a variety of applications. The paper itself can be shaped into different designs and the material’s electrical conduction properties can be tuned from 1012 to 10–2 Ω cm – values that exceed those of previously-reported 3D semiconducting materials – by changing the concentration of charge carriers (electrons and holes) in it. This means it is suitable for use in many devices, from water vapour sensors to electrodes in enzymatic biofuel cells.

Read more | >

Cell-Based Dairy Bio-Products For Health & Nutrition — Dr. Aletta Schnitzler, Ph.D. — CSO — Turtletree Labs

Dr. Aletta Schnitzler, PhD. is the Chief Scientific Officer at TurtleTree Labs (https://turtletree.com/) where she leads the R&D teams and spearheads an innovation roadmap to bring nutritious cell-based dairy and meat alternatives to market.

TurtleTree is a biotech company dedicated to producing a new generation of nutrition—one that’s better for the planet, better for the animals, and better for people everywhere. Utilizing its proprietary, cell-based technology, the company is creating “better-for-you” milk ingredients sustainably and affordably, with benefits that extend beyond the dining table and into the heart of humanity.

Continue reading “Dr Aletta Schnitzler — CSO — TurtleTree Labs — Cell-Based Dairy Bio-Products For Health & Nutrition” | >

A mechanism that causes autism, schizophrenia, Alzheimer’s and other conditions and is shared by mutations in the genes ADNP and SHANK3 has been unraveled by Tel Aviv University researchers who developed an experimental drug they found to be effective in animal models.

The drug could also be suitable for treating a range of rare syndromes that impair brain functions, said the scientists. The researchers were led by Prof. Illana Gozes from the Department of Human Molecular Genetics and Biochemistry at TAU’s Sackler Faculty of Medicine and the Sagol School of Neuroscience. The experimental drug, called Davunetide, had previously been developed in her lab.

The paper, which the team called a “scientific breakthrough,” was published in the scientific journal Molecular Psychiatry under the title “SH3-and actin-binding domains connect ADNP and SHANK3, revealing a fundamental shared mechanism underlying autism.”

Read more | >